Evidence map›Paper›PMID 41892811›Full record

ReviewJournal of developmental biology2026

SIX3 as a Regulator of Development and Disease.

Ana Beatriz Matos, Laura Jesus Castro, Torcato Martins

Abstract readReview
In one paragraph

Review in Journal of developmental biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ana Beatriz MatosDepartment of Medical Sciences, Institute of Biomedicine, University of Aveiro, Agra do Crasto, 3810-193 Aveiro, Portugal.ORCID 0009-0004-8300-1849
Laura Jesus CastroDepartment of Medical Sciences, Institute of Biomedicine, University of Aveiro, Agra do Crasto, 3810-193 Aveiro, Portugal.ORCID 0000-0002-1869-1984
Torcato MartinsDepartment of Medical Sciences, Institute of Biomedicine, University of Aveiro, Agra do Crasto, 3810-193 Aveiro, Portugal.ORCID 0000-0002-9359-7111

Funding

Fundação para a Ciência e Tecnologia 10.54499/2022.02406.CEECIND/CP1720/CT0014Fundação para a Ciência e Tecnologia 2024.04340.BDFundação para a Ciência e Tecnologia UID/04501/2025Fundo Europeu de Desenvolvimento Regional COMPETE2030-FEDER-00726500
6 · The paper itself

Abstract

Transcriptional regulation is pivotal for developmental processes and cell fate specification in homeostasis. One particularly relevant group of transcription factors is the sine oculis homeobox (SIX) family, which is involved in a wide range of molecular processes from development to tissue maintenance. Within this family, distinct subfamilies exhibit specific DNA-binding preferences and can function as transcriptional activators or repressors. In this review, we focus on the Optix/SIX3-SIX6 subfamily and discuss their roles as transcriptional regulators, as well as the consequences of their deregulation for neuronal and ocular development and for the maintenance of tissue homeostasis. We further examine how SIX3 can act either as a tumour suppressor or as a marker of poor prognosis in different cancer types. Moreover, we summarize recent findings on the role of SIX3 in pancreatic β cells and highlight emerging evidence that SIX2 also contributes to β-cell identity and regulatory stability. Downregulation of SIX2 and SIX3 alters gene regulatory programs associated with β-cell homeostasis and contributes to type 2 diabetes. As accumulating evidence links members of the SIX family to cancer and metabolic disease, it is crucial to characterize how these transcription factors regulate cell identity, with important implications for disease mechanisms and therapeutic strategies.

Indexed as

neuronal development and homeostasisoncogenesisOptix/SIX3SIX transcription factorstranscriptional regulationtype-II diabetes

Identifiers

PMID41892811
PMCPMC13026914

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.